Portal vein thrombosis during antineoplastic chemotherapy in children: report of five cases and review of the literature

Eur J Cancer. 2004 Dec;40(18):2659-66. doi: 10.1016/j.ejca.2004.06.013.

Abstract

We report five paediatric cases of portal vein thrombosis (PVT) occurring during chemotherapy, observed in two institutions over an 8-year time period. These children aged 2.5-15 years were treated for Burkitt's lymphoma, Ewing's tumour, small cell bone tumour or medulloblastoma. PVT was diagnosed on colour Doppler ultrasonography (US). In four patients, thrombosis occurred 2-45 days after severe hepatic veno-occlusive disease (HVOD) secondary to intensive chemotherapy containing busulfan. In one case, PVT occurred in the absence of HVOD in a patient with pre-existing periportal lymphomatous infiltration. Four patients experienced persistent portal hypertension, which resulted in death in one. PVT during chemotherapy in children is a rare event and appears to be closely related to intensive chemotherapy containing busulfan and to be associated with HVOD.

Publication types

  • Case Reports
  • Multicenter Study
  • Review

MeSH terms

  • Adolescent
  • Anticoagulants / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Child
  • Child, Preschool
  • Female
  • Heparin / therapeutic use
  • Humans
  • Male
  • Neoplasms / drug therapy*
  • Portal Vein*
  • Risk Factors
  • Treatment Outcome
  • Venous Thrombosis / chemically induced*
  • Venous Thrombosis / drug therapy

Substances

  • Anticoagulants
  • Antineoplastic Agents
  • Heparin